| Xeloda Side Effect Report | Date Submitted |
|---|---|
| numbness in left arm, chest pain and jaw pain | 2011-11-06 |
Xeloda Side Effect Reports Summary
PatientsVille.com - Empowering Patients
Xeloda Studies
Second Line Therapy in Advanced Biliary Tract Cancer
Low Dose of Metronomic Cyclophosphamide and Capecitabine in Pretreated HER2-negative Metastatic Breast Cancer
Capecitabine, Temozolomide and Bevacizumab for Metastatic or Unresectable Pancreatic Neuroendocrine Tumors
Perioperative Chemotherapy for Potentially Resectable Gastric Cancer
A Study of Capecitabine Rapid Disintegrating Tablets (RDT) Versus Commercial Xeloda in Patients With Solid Tumours
The BEACON Study (Breast Cancer Outcomes With NKTR-102)
Study of GEMOX(Gemcitabine/Oxaliplatin) Versus XELOX(Xeloda/Oxaliplatin) in Advanced Biliary Tract Carcinoma
A Multicenter Phase II Study of Neoadjuvant Docetaxel, Cisplatin and Capecitabine and Protocolized Surgery in Resectable Gastric Cancer
A Study of Herceptin (Trastuzumab) in Combination With Cisplatin/Capecitabine Chemotherapy in Patients With HER2-Positive Metastatic Gastric or Gastro-Esophagea
An Observational Study of Adjuvant Treatment With Xeloda (Capecitabine) in Combination With Oxaliplatin in Patients With Stage III Colon Cancer
Study of Ruxolitinib in Pancreatic Cancer Patients
An Observational Study of Avastin (Bevacizumab) in Combination With Xeloda (Capecitabine) And Oxaliplatin in Patients With Colorectal Cancer
Safety Study of Combined Systemic and Intraperitoneal Chemotherapy to Treat Stomach Cancer
E7050 in Combination With Cisplatin and Capecitabine Versus Cisplatin and Capecitabine Alone in Patients With Advanced or Metastatic Solid Tumors and Previously
A Phase 1b/2, Multicenter, Randomized, Open-Label, Dose-Escalation and Confirmation Study of Eribulin in Combination With Capecitabine
Safety and Efficacy Study of Gemcitabine-erlotinib Versus Gemcitabine-erlotinib-capecitabine in Patients With Metastatic Pancreatic Cancer
Prevention of Capecitabine Induced Hand and Foot Syndrome
A Study of Herceptin (Trastuzumab) in Combination With Xeloda (Capecitabine) in Patients With Metastatic or Recurrent HER2-positive Breast Cancer After First-Li
An Observational Study of Xeloda (Capecitabine) Monotherapy in Patients With Colorectal Cancer (AXEL)
Combination Chemotherapy Plus Bevacizumab With or Without Oxaliplatin in Treating Older Patients With Metastatic Colorectal Cancer
Phase III Trial Comparing Capecitabine in Combination With Sorafenib or Placebo in the Treatment of Locally Advanced or Metastatic HER2-Negative Breast Cancer
CAPOX in KRAS Wild-Type Advanced Adenocarcinoma of the Small Bowel or Ampulla of Vater
Role of Early Versus Late Switch to Lapatinib-Capecitabine (TYCO)
Dual REctcal Angiogenesis or MEK Inhibition radioTHERAPY Trial
Gemcitabine, Cisplatin, Epirubicin, and Capecitabine in Treating Patients With Stage I-II Resectable Pancreatic Cancer
A Phase I Study of AZD6244 in Combination With Capecitabine and Radiotherapy in Locally Advanced Adenocarcinoma of the Rectum
A Study of Capecitabine [Xeloda] in Combination With Trastuzumab [Herceptin] and Oxaliplatine in Patients With Resectable Gastric Cancer
Randomized Study With Oxaliplatin in 2nd Line Pancreatic Cancer
Trial of XP (Capecitabine/CDDP) Simvastatin in Advanced Gastric Cancer Patients
A Study of a Combination of Trastuzumab and Capecitabine With or Without Pertuzumab in Patients With HER2-positive Metastatic Breast Cancer (PHEREXA)
Gemcitabine Hydrochloride With or Without Erlotinib Hydrochloride Followed By the Same Chemotherapy Regimen With or Without Radiation Therapy and Capecitabine o
Lapatinib in Combination With Vinorelbine
Docetaxel, Oxaliplatin, Capecitabine, Fluorouracil, and Radiation Therapy in Treating Patients With Locally Advanced Cancer of the Esophagus or Gastroesophageal
A Study of Avastin (Bevacizumab) + Xeloda (Capecitabine)as Maintenance Therapy in Patients With HER2-Negative Metastatic Breast Cancer
Xeloda (Capecitabine) and External Beam Radiation
A Study of BMS-833923 With Cisplatin and Capecitabine in Inoperable, Metastatic Gastric, Gastroesophageal, or Esophageal Adenocarcinomas
ATX Study:A Study of Avastin (Bevacizumab), Tarceva (Erlotinib) and Xeloda (Capecitabine) in Patients With Locally Advanced and/or Metastatic Pancreatic Cancer
An Open-Label Study of Trastuzumab Emtansine (T-DM1) vs Capecitabine+Lapatinib in Patients With HER2-Positive Locally Advanced or Metastatic Breast Cancer (EMIL
Lapatinib Plus Capecitabine Versus Trastuzumab Plus Capecitabine in ErbB2 (HER2) Positive Metastatic Breast Cancer.
Ph II of Capecitabine, Carboplatin & Bevacizumab for Gastroesophageal Junction & Gastric Carcinoma
Capiri-sutent Phase-1 in Advanced Colo-rectal Cancer
Brain Mets - Capecitabine and WBRT
A Study of Xeloda (Capecitabine) as Adjuvant Monotherapy in Patients With Colon Cancer.
You took Xeloda and now feel unusual symptoms. It could be Xeloda side effect. Help Community - Submit Your Side Effect.
Mobile version
How Did You Deal with Side Effects?About Xeloda : Risks and Benefits, News and Updates, Xeloda video and TV resources<<<<
Xeloda Side Effects - Complete Patient's Guide | User Reviews: Male patient, 50 years of age, was diagnosed |Abdominal Pain|Xeldoa Gastristis|Rash|Joint Pain|Severe ...<<<<
Xeloda Side Effects Reported and Ranked by Xeloda Users |Abdominal Pain|Xeldoa Gastristis|Rash|Joint Pain|Severe Bone Pain|Arrhythmia)|Itching Rash|Diareha Stomach ...<<<<
Side Effects of Xeloda Discussions: Patient comment about their Xeloda side effects experience.<<<<
Xeloda dosage: Patient Completed One Cycle Of Capecitabine.. Patient died on 04/19/2008. Xeloda Side Effects Report: 5733196-X,Malignant Neoplasm Progression, ...<<<<
The inactive ingredients in XELODA include ... Xeloda dose and Xeloda uses Each light peach-colored tablet contains 150 mg capecitabine and each peach-colored tablet ...<<<<
During the same period patient was treated with XELODA (View Xeloda Review and Xeloda Label ), CLONAZEPAM (View Clonazepam Review and Clonazepam Label ).<<<<
During the same period patient was treated with XELODA (View Xeloda Review and Xeloda Label ), AVASTIN (View Avastin Review and Avastin Label ), PARIET (View Pariet Review and ...<<<<
During the same period patient was treated with CISPLATIN (Recent Inf:21jul2010 On Day 1 Of Cycle) (View Cisplatin Review and Cisplatin Label ), XELODA (Recent Inf:04aug2010 ...<<<<
During the same period patient was treated with XELODA (View Xeloda Review and Xeloda Label ), ELPLAT (View Elplat Review and Elplat Label ), LOXONIN (View Loxonin Review and ...<<<<